EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance

Monika Gawałko iD, Arnela Saljic iD, Na Li iD, Issam Abu-Taha iD, Thomas Jespersen iD, Dominik Linz iD, Stanley Nattel iD, Jordi Heijman iD, Anke Fender iD, Dobromir Dobrev iD

Cardiovascular Research · 02.05.2023 · 119 (3) · 614-630

DOI: 10.1093/cvr/cvac093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 11.06.2022. Verfasst von Monika Gawałko und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Hufelandstraße 55, 45147 Essen, Germany. Hauptthemen laut MEDLINE: Adiposity, Atrial Fibrillation. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is an important contributing factor to the pathophysiology of atrial fibrillation (AF) and its complications by causing systemic changes, such as altered haemodynamic, increased sympathetic tone, and low-grade chronic inflammatory state. In addition, adipose tissue is a metabolically active organ that comprises various types of fat deposits with discrete composition and localization that show distinct functions. Fatty tissue differentially affects the evolution of AF, with highly secretory active visceral fat surrounding the heart generally having a more potent influence than the rather inert subcutaneous fat. A variety of proinflammatory, profibrotic, and vasoconstrictive mediators are secreted by adipose tissue, particularly originating from cardiac fat, that promote atrial remodelling and increase the susceptibility to AF. In this review, we address the role of obesity-related factors and in particular specific adipose tissue depots in driving AF risk. We discuss the distinct effects of key secreted adipokines from different adipose tissue depots and their participation in cardiac remodelling. The possible mechanistic basis and molecular determinants of adiposity-related AF are discussed, and finally, we highlight important gaps in current knowledge, areas requiring future investigation, and implications for clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdiposityAtrial FibrillationHumansClinical RelevanceObesityAdipose TissuePericardium

Stichwörter der Autor:innen

AdipokinesAtrial fibrillationEpicardial adipose tissueNLRP3 inflammasomeObesitySubcutaneous adipose tissueVisceral adipose tissue

Autor:innen und Institutionen

  • Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Hufelandstraße 55, 45147 Essen, Germany.
  • 1st Department of Cardiology, Medical University of Warsaw, Banacha 1A, 02-197 Warsaw, Poland.
  • Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
  • Department of Medicine (Section of Cardiovascular Research), Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
  • Department of Molecular Physiology and Biophysics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.

ORCID-Profile: Monika Gawałko, Arnela Saljic, Na Li, Issam Abu-Taha, Thomas Jespersen, Dominik Linz, Stanley Nattel, Jordi Heijman, Anke Fender, Dobromir Dobrev

Förderung

  • NHLBI NIH HHS
  • Canadian Institutes of Health Research
  • Heart and Stroke Foundation of Canada
  • National Institutes of Health
  • German Research Foundation
  • Horizon 2020 programme
  • European Union
  • MEASTRIA

Zitieren

APA

Gawałko, M., Saljic, A., Li, N., Abu-Taha, I., Jespersen, T., Linz, D., Nattel, S., Heijman, J., Fender, A., & Dobrev, D. (2023). Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance. Cardiovascular Research, 119(3), 614-630. https://doi.org/10.1093/cvr/cvac093

Vancouver

Gawałko M, Saljic A, Li N, Abu-Taha I, Jespersen T, Linz D, et al. Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance. Cardiovascular Research. 2023;119(3):614-630. doi:10.1093/cvr/cvac093

BibTeX
@article{Gawako2023,
  author = {Gawałko, Monika and Saljic, Arnela and Li, Na and Abu-Taha, Issam and Jespersen, Thomas and Linz, Dominik and Nattel, Stanley and Heijman, Jordi and Fender, Anke and Dobrev, Dobromir},
  title = {Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance},
  journal = {Cardiovascular Research},
  year = {2023},
  volume = {119},
  number = {3},
  pages = {614--630},
  doi = {10.1093/cvr/cvac093}
}
Kostenlos starten →